Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years and account for ~ 20% of COVID-19 deaths자가항체 중화 I형 IFN은 70세 이상 감염되지 않은 개인의 약 4%에 존재하며 COVID-19 사망자의 약 20%를 차지합니다.Article Published on 2021-10-082022-09-12 Journal: Science Immunology [Category] Fulltext, MERS, 진단, [키워드] age antibody asymptomatic infections auto auto-Ab auto-Abs autoantibody Concentration COVID-19 COVID-19 case COVID-19 pneumonia Critical death Deceased detect Dilution fatal COVID-19 General population greater IFN-α IFN-β increase in individual Neutralizing Patient physiological plasma Pneumonia Prevalence proportion SARS-COV-2 infection severe COVID-19 subject Type I IFN type I IFNs underlie uninfected [DOI] 10.1126/sciimmunol.abl4340 PMC 바로가기 [Article Type] Article
An ultrafast SARS-CoV-2 virus enrichment and extraction method compatible with multiple modalities for RNA detectionRNA 검출을 위한 다중 양식과 호환되는 초고속 SARS-CoV-2 바이러스 농축 및 추출 방법Randomized Controlled Trial Published on 2021-10-022022-09-11 Journal: Analytica chimica acta [Category] MERS, SARS, 임상, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus affinity Affinity nanoparticles alternative method alternative methods amplification Analysis Chain Reaction characterization characterized clinical samples clinically comparable compatibility Concordance coronavirus Coronavirus-2 COVID-19 pandemic demonstrated diagnoses Dilution dilutions double-blind study Enzymatic extraction form isothermal amplification Laboratory LAMP Loop-mediated amplification (LAMP) Loop-mediated isothermal amplification miniaturization nasopharyngeal swabs Particle pathogenicity polymerase polymerase chain polymerase chain reaction Polymerase chain reaction (PCR) positive recombinase polymerase amplification Recombinase polymerase amplification (RPA) respiratory reverse transcription reverse transcription real-time polymerase chain reaction RNA RNA eluate RNA isolation RNA virus RPA RT-PCR Saliva SARS-CoV-2 SARS-CoV-2 viral SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus-2 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) solution Stage the stage transmission rate Viral viral titer viral titers viral transport media VTM zoonotic [DOI] 10.1016/j.aca.2021.338846 PMC 바로가기 [Article Type] Randomized Controlled Trial
Evaluation of false positives in the SARS-CoV-2 quantitative antigen testSARS-CoV-2 정량 항원 검사에서 위양성 평가Article Published on 2021-10-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] SARS, 치료기술, [키워드] anti-SARS-CoV-2 antibody Antigen automated caused centrifugation Characteristics collected decrease detection Diagnosis Dilution False positive False-positive false-positives Frequency Laboratory NAAT nasopharyngeal nasopharyngeal sample Nasopharyngeal samples Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples Negative predictive value non-specific Non-specific reaction novel Novel coronavirus nucleic acid nucleic acid amplification nucleic acid amplification test performed positive Predictive value Quantitative reaction reagent Saliva saliva samples SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens the SARS-CoV-2 [DOI] 10.1016/j.jiac.2021.06.019 PMC 바로가기 [Article Type] Article
Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaignLetter to the Editor Published on 2021-09-302022-10-31 Journal: Environmental health and preventive medicine [Category] COVID-19, SARS, [키워드] Administered adopted Adverse reactions Care carried collected composed concerning Coverage COVID-19 database development Dilution dose doses employment first dose Health profession healthcare worker hospital hygiene immunization Innovation management Moderna mRNA vaccine Nurses objective observation operative operators Pathways per day Pfizer professional protocol public health Result SARS-CoV-2 subject subjects target the SARS-CoV-2 the vaccine Treatment turnaround time unit vaccination Vaccination campaign Vaccine vaccine dose [DOI] 10.1186/s12199-021-01018-z PMC 바로가기 [Article Type] Letter to the Editor
“First Do No Harm”. No-Fault Compensation Program for COVID-19 Vaccines as Feasibility and Wisdom of a Policy Instrument to Mitigate Vaccine HesitancyReview Published on 2021-09-302022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] administration adverse event adverse events approved compensation COVID-19 COVID-19 vaccination COVID-19 vaccine Dilution effective Efficacy Europe European European country excluded General population Government healthcare Hesitancy individual Injury instrument introduced Italian Italy law management mandatory no-fault compensation physical Policy Program reported Safe solidarity urgency vaccination Vaccine Vaccine hesitancy [DOI] 10.3390/vaccines9101116 PMC 바로가기 [Article Type] Review
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 PatientsResearch Article Published on 2021-09-222022-10-30 Journal: Microbiology Spectrum [Category] COVID-19, MERS, SARS, [키워드] 95% CI 95% confidence interval acute phase acute respiratory syndrome administration age anti-SARS-CoV-2 antibody antibodies antibody Characteristics China collected conducted convalescent COVID-19 patient Convalescent patients coronavirus coronavirus disease COVID-19 COVID-19 convalescent patient COVID-19 patient Dilution discharge discharged disease severity enrolled Evidence Factor Follow-up follow-up period follow-up time geometric mean titer GMT hospital IgG IgM IgM/IgG immune response inhibitory interquartile range Jiangsu Kinetics male median Month natural infection Neutralizing activity neutralizing antibody Onset participant Patient patients persistence plasma sample produced SARS-CoV-2 serological seropositive serum sample severity significantly higher significantly lower Specific Standard deviation symptom onset tested Vaccine virus dynamics with COVID-19 [DOI] 10.1128/Spectrum.00590-21 PMC 바로가기 [Article Type] Research Article
Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2SARS-COV-2의 검출을위한 19 개의 상업적으로 이용 가능한 빠른 항원 시험의 상이한 매트릭스에서 검출 한계Comparative Study Published on 2021-09-152022-09-01 Journal: Scientific Reports [Category] SARS, 변종, 유전자 메커니즘, 진단, 치료기술, [키워드] Ag-RDT Amy analytical sensitivity antigen-detection applied coronavirus disease Coronavirus disease 2019 COVID-19 criteria culture media culture supernatant defined diagnostic tests Dilution Excalibur exceeded fold Genome Health Organization Immunochemistry investigated Laboratory techniques and procedures limit of detection live SARS-CoV-2 media Orient pandemic rapid antigen test Rapid diagnostic test Roche SARS-CoV-2 sensitivity serial dilutions Swab the SARS-CoV-2 viral infection World Health Organization [DOI] 10.1038/s41598-021-97489-9 PMC 바로가기 [Article Type] Comparative Study
In-house reverse transcriptase polymerase chain reaction for detection of SARS-CoV-2 with increased sensitivity증가 된 감도와 SARS-COV-2의 검출을위한 사내 역전사 효소 중합 효소 연쇄 반응Article Published on 2021-09-092022-09-01 Journal: Scientific Reports [Category] SARS, 변종, 진단, 치료기술, 치료제, [키워드] added advent amplification amplify amplifying applicability approach concentrations Concordance COVID-19 disease COVID-19 infection COVID-19 test demonstrated Dilution Epidemiology help management multiplex Multiplex PCR Multiplexing offer pandemic PCR condition polymerase chain positive sample primer Primers RdRP real time Real-time PCR relief resource RT-PCR SARS-CoV-2 SARS-CoV-2 genes sensitivity sets of primers shown significantly SYBR Green the SARS-CoV-2 transcriptase variable [DOI] 10.1038/s41598-021-97502-1 PMC 바로가기 [Article Type] Article
Optimal uses of pooled testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An application to congregate settings in Los Angeles CountyMulticenter Study Published on 2021-09-012023-07-02 Journal: Journal of medical virology [Category] SARS, [키워드] congregate setting cost saving COVID-19 Dilution pooled testing Skilled nursing facilities [DOI] 10.1002/jmv.27054 PMC 바로가기 [Article Type] Multicenter Study
Evaluation of a PlexZyme -Based PCR Assay and Assessment of COVID-19 Surge Testing Throughput Compared to Cobas SARS-CoV-2Article Published on 2021-08-262022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] assessment component correlation COVID-19 COVID-19 testing decrease demonstrated Dilution evaluated High-throughput less log median negative sample ORF1a ORF1ab outcome PCR PlexZyme positive Quantitative quantitative PCR reproducibility required Research Respiratory Coronavirus Roche SARS-CoV-2 Testing throughput was tested [DOI] 10.3390/pathogens10091088 PMC 바로가기 [Article Type] Article